NCT05671549

Brief Summary

The goal of this prospective cohort study is to evaluate the effectiveness of combined arthrocentesis and occlusal stabilization splint therapy in patients diagnosed with disc displacement without reduction of temporomandibular joint-induced closed locks. The main questions it aims to answer are:

  • Is there a difference in the treatment response between chronic and acute closed-lock conditions?
  • On which dimensions of pain did the treatment have positive effects? Participants will be preoperatively examined and assigned to one of the two study groups.
  • All participants undergo a single session of TMJ arthrocentesis.
  • Following the arthrocentesis session, all participants will use preoperatively fabricated occlusal splints.
  • Participants will be recalled in one week to evaluate the outcomes. Researchers will compare acute and chronic closed-lock groups to see if there are differences between pain intensities and mouth-opening amounts postoperatively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 29, 2019

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2021

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 2, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 4, 2023

Completed
Last Updated

January 4, 2023

Status Verified

January 1, 2023

Enrollment Period

2.2 years

First QC Date

January 2, 2023

Last Update Submit

January 3, 2023

Conditions

Keywords

ArthrocentesisClosed lockStabilization splint

Outcome Measures

Primary Outcomes (5)

  • Baseline Pain intensity with Visual analog scale

    The pain intensity measurement was performed with the Visual analog scale (VAS), in which 0 referred to 'no pain,' 5 referred to 'moderate pain,' and ten referred to 'excruciating pain.' The patients were asked to mark their pain intensities on the VAS scale.

    At the initial visit before arthrocentesis procedure.

  • Baseline Pain intensity with McGill pain questionnaire

    The pain intensity measurement was performed with the McGill Pain Questionnaire form. According to the word groups chosen by the participants, the total score of the questionnaire varies between 0-78. An increase in the total score is interpreted as the severity of pain intensity.

    At the initial visit before arthrocentesis procedure.

  • Change From Baseline Maximum Mouth Opening on Postoperative Follow Up Visits

    All patients' maximal mouth opening were measured and recorded as the distance between upper and lower right central incisors.

    At the initial visit, at the session of arthrocentesis postoperatively, at the first week

  • Postoperative Pain intensity with Visual analog scale

    The pain intensity measurement was performed with the Visual analog scale (VAS), in which 0 referred to 'no pain,' 5 referred to 'moderate pain,' and ten referred to 'excruciating pain.' The patients were asked to mark their pain intensities on the VAS scale.

    At first week follow-up visit

  • Postoperative Pain intensity with McGill pain questionnaire

    The pain intensity measurements were performed with the McGill Pain Questionnaire form. According to the word groups chosen by the participants, the total score of the questionnaire varies between 0-78. An increase in the total score is interpreted as the severity of pain intensity.

    At first week follow-up visit

Study Arms (2)

Chronic Closed-Lock

ACTIVE COMPARATOR

The participants will be enrolled in this group regarding the duration (longer than three months) of their symptoms. The allocated participants will undergo one session of the arthrocentesis procedure. The prefabricated occlusal stabilization splints will be applied. The participants' preoperative, postoperative immediate, and postoperative seventh-day pain intensities and maximum mouth-opening amounts will be recorded and analyzed.

Procedure: Arthrocentesis of the temporomandibular joint

Acute Closed-Lock

ACTIVE COMPARATOR

The participants will be enrolled in this group regarding the duration (shorter than three months) of their symptoms. The allocated participants will undergo one session of the arthrocentesis procedure. The prefabricated occlusal stabilization splints will be applied. The participants' preoperative, postoperative immediate, and postoperative seventh-day pain intensities and maximum mouth-opening amounts will be recorded and analyzed.

Procedure: Arthrocentesis of the temporomandibular joint

Interventions

Arthrocentesis of the temporomandibular joint is a minimally invasive method performed under local anesthesia to irrigate the upper temporomandibular joint cavity with biocompatible substances. The procedure aims to wash out intra-articular inflammatory substances, reduce pain and restore the function of the related joint.

Acute Closed-LockChronic Closed-Lock

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • individuals over the age of 18
  • completion of the arthrocentesis treatment without any complications;
  • the presence of preoperative information and postoperative follow-up data;
  • persistent complaints despite conservative methods (behavioral modification, diet restrictions, non-steroid anti-inflammatory drugs, and physical therapy) for at least three months.

You may not qualify if:

  • diagnosed with any connective tissue, neurological, dermatological, inflammatory diseases, and TMD other than DDWoR,
  • who underwent TMJ surgeries, arthrocentesis procedures, TMJ ankylosis surgery,
  • previously used occlusal splints,
  • who developed complications in the application of arthrocentesis in the current study (low-volume lavage, extravasation, inability to reach the upper joint space, e.g.),
  • with lack of teeth to affect the fabrication of the occlusal stabilization splint,
  • with a history of radiotherapy of the head and neck.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tokat Gaziosmanpasa University, Faculty of Dentistry

Tokat Province, 60100, Turkey (Türkiye)

Location

Related Publications (3)

  • Hosgor H. Is arthrocentesis plus hyaluronic acid superior to arthrocentesis alone in the treatment of disc displacement without reduction in patients with bruxism? J Craniomaxillofac Surg. 2020 Nov;48(11):1023-1027. doi: 10.1016/j.jcms.2020.07.008. Epub 2020 Jul 25.

    PMID: 33028488BACKGROUND
  • Tatli U, Benlidayi ME, Ekren O, Salimov F. Comparison of the effectiveness of three different treatment methods for temporomandibular joint disc displacement without reduction. Int J Oral Maxillofac Surg. 2017 May;46(5):603-609. doi: 10.1016/j.ijom.2017.01.018. Epub 2017 Feb 20.

  • Erdil A, Demirsoy MS, Tumer MK. Evaluation of the effects of arthrocentesis combined with occlusal stabilization splint on disc displacement without reduction-induced acute and closed lock. A prospective cohort study. J Stomatol Oral Maxillofac Surg. 2023 Oct;124(5):101438. doi: 10.1016/j.jormas.2023.101438. Epub 2023 Mar 12.

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Study Officials

  • Mehmet K. Tümer, AssocProfDr

    Alanya Alaaddin Keykubat University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher in the related department

Study Record Dates

First Submitted

January 2, 2023

First Posted

January 4, 2023

Study Start

May 29, 2019

Primary Completion

August 25, 2021

Study Completion

June 10, 2022

Last Updated

January 4, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

The data regarding participants were made available in the manuscript

Locations